Matinas BioPharma Holdings, Inc. (MTNB)
0.1842
0.00 (0.00%)
USD |
NYAM |
Sep 09, 10:55
Matinas BioPharma Holdings Shareholders Equity (Quarterly) : 1.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.80M |
| March 31, 2026 | 3.022M |
| December 31, 2025 | 4.83M |
| September 30, 2025 | 6.46M |
| June 30, 2025 | 7.675M |
| March 31, 2025 | 6.27M |
| December 31, 2024 | 7.59M |
| September 30, 2024 | 15.78M |
| June 30, 2024 | 19.10M |
| March 31, 2024 | 14.56M |
| December 31, 2023 | 19.25M |
| September 30, 2023 | 23.15M |
| June 30, 2023 | 27.85M |
| March 31, 2023 | 32.62M |
| December 31, 2022 | 36.64M |
| September 30, 2022 | 38.62M |
| June 30, 2022 | 42.85M |
| March 31, 2022 | 47.68M |
| December 31, 2021 | 52.49M |
| September 30, 2021 | 58.25M |
| June 30, 2021 | 62.90M |
| March 31, 2021 | 66.56M |
| December 31, 2020 | 63.73M |
| September 30, 2020 | 68.21M |
| June 30, 2020 | 72.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 77.60M |
| December 31, 2019 | 33.05M |
| September 30, 2019 | 37.98M |
| June 30, 2019 | 40.42M |
| March 31, 2019 | 43.01M |
| December 31, 2018 | 16.14M |
| September 30, 2018 | 10.30M |
| June 30, 2018 | 12.53M |
| March 31, 2018 | 8.434M |
| December 31, 2017 | 10.68M |
| September 30, 2017 | 12.78M |
| June 30, 2017 | 15.21M |
| March 31, 2017 | 18.86M |
| December 31, 2016 | 7.15M |
| September 30, 2016 | 8.722M |
| June 30, 2016 | 2.997M |
| March 31, 2016 | 4.220M |
| December 31, 2015 | 6.072M |
| September 30, 2015 | 6.961M |
| June 30, 2015 | 8.629M |
| March 31, 2015 | 6.393M |
| December 31, 2014 | 2.228M |
| September 30, 2014 | 4.746M |
| June 30, 2014 | 6.458M |
| March 31, 2014 | 8.610M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.412M |
| Total Liabilities (Quarterly) | 1.612M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 0.8467 |
| Net Debt Paydown Yield | 13.81% |